Atlas Trials

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

Clinical trial NCT05049538 · RECRUITING

Trial details

NCT number
NCT05049538
Sponsor
M.D. Anderson Cancer Center
Status
RECRUITING
Study type
OBSERVATIONAL
Endometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Mucinous AdenocarcinomaEndometrial Serous AdenocarcinomaMalignant Uterine NeoplasmUterine Corpus Carcinosarcoma
Start date
2019-06-18
Primary completion
2028-06-30
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.